Duality Biotherapeutics, Inc. (HKG:9606)

Hong Kong · Delayed Price · Currency is HKD

315.60

+24.40 (8.38%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Biotechnology	1.94B	1.79B
Biotechnology Growth	8.66%	-
Total	1.94B	1.79B
Total Growth	8.66%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
China	1.94B	1.79B
China Growth	8.66%	-
Total	1.94B	1.79B
Total Growth	8.66%	-

Source: S&P Global Market Intelligence.